Wegovy 1.7mg

Wegovy 1.7 mg is an injectable medication that’s used to trigger weight loss. Its active ingredient is Semaglutide which is a GLP-1 (glucagon-like peptide-1) receptor agonist. It works by mimicking the GLP-1 hormone and helps adolescents and adults lose weight. Wegovy 1.7 mg can also be used to protect high-risk individuals from cardiovascular complications or treat MASH, which is a serious liver condition. 

Key Features

How does Wegovy 1.7 mg work?

The active ingredient in Wegovy 1.7 mg is semaglutide. Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist that mimics the GLP-1 hormone that’s naturally produced by the body’s gut. GLP-1 activates the brain areas that are involved in hunger and satiety, which keeps an individual fuller for longer and reduces their hunger cravings. A person can substantially decrease their caloric intake through this process. 

It triggers the production of insulin and reduces the glucagon that’s produced by the liver. In doing so, an individual’s blood sugar levels stay regulated. Along with this, semaglutide also slows down the speed of gastric emptying. By doing so, the person feels fuller for a longer period of time. The Wegovy 1.7 mg helps the person lose weight in this process. 

Dosage

Any individual should speak with their healthcare provider before starting to take Wegovy 1.7 mg, but here are a few guidelines that should be kept in mind:

• The Wegovy 1.7 mg injection is supposed to be administered once a week and at the same time each week. 
• You can inject the medication into the abdomen, thigh, or upper arm areas of the body. It’s important to keep rotating the injection site after each use so that the skin doesn’t get too irritated. It’s okay if the general area of application is the same.
• Make sure that the yellow bar in the pen window has completely stopped moving before you remove the pen from your skin.
• If a dose has been missed, then try to take it as soon as you remember, but if the next dose is in 2 days (48 hours), then skip the dose and take the next one. 
• Do not freeze your Wegovy 1.7 mg pen. 

Uses

Wegovy 1.7 mg is typically suggested in the following situations:

• To manage chronic obesity in adults or adolescents.
• To support long-term weight management plans and trigger weight loss.
• To treat adults with metabolic liver disease (MASH).

Side Effects

Some mild side effects you may see are:

• Headaches
• Nausea 
• Diarrhea, constipation, or mild abdominal discomfort
• Fatigue
• Dizziness
• Vomiting

Rare but serious side effects you should watch out for:

• Extreme allergic reactions like swelling in the facial area, lips, or throat.
• Changes in vision.
• Extremely low blood sugar
• Signs of pancreatitis 
• Decreased urination or swelling in legs, ankles, or feet.
• A lump or swelling in the neck.

Try to get expert medical attention if you end up experiencing any of these serious side effects. 

Interactions

Insulin & Diabetes medications

Using the Wegovy 1.7 mg injection with insulin, sulfonylureas, or other medications that decrease blood sugar can increase the risk of an individual experiencing severely low blood sugar, i.e., hypoglycemia.

Oral Medications & Contraceptives

When you take Wegovy 1.7 mg, it can influence how soon any other oral medications taken around the same time get absorbed by the body. You may have to take the other medications at another time. 

Blood thinners

If an individual is using blood thinners like warfarin or others, they should closely monitor their blood clotting time since Wegovy can affect the effectiveness of these blood thinners.

Blood pressure medications

Wegovy can lead to a lower blood pressure. If an individual is already taking blood pressure medications, like ACE inhibitors or beta-blockers, then they run the risk of having a blood pressure that’s too low. It might lead to dizziness or lightheadedness, which is why caution should be exercised.

Precautions and Safety Warnings

• Anyone who has a history of pancreatitis should avoid using Wegovy 1.7 mg.
• Rapidly losing weight and dehydration can cause kidney and gallbladder problems.
• People who have severe gastroparesis or stomach paralysis should avoid taking semaglutide since it slows down digestion.
• If a woman plans to conceive, then she should stop using Wegovy 1.7 mg at least two months before conception since it’s not suitable for pregnant or breastfeeding women.  
• If you have a history of diabetic retinopathy, then you should be attentive to any changes in vision that may potentially happen. 

Conclusion

Wegovy 1.7 mg is a huge advancement in the field of weight loss and management. By making use of the GLP-1 pathways, it manages to not only trigger weight loss but also provide protection against cardiovascular problems or treat metabolic liver diseases like MASH. It also regulates the blood glucose levels and can help with Type 2 diabetes. Pairing the Wegovy 1.7 mg with a diet low in calories and enough exercise can help any individual meet their weight loss goals.  

FAQs